EONE-DIAGNOMICS Genome Center (EDGC), a global company in genetic analysis, has announced the release of a liquid biopsy screening service this autumn. EDGC has been developing the liquid biopsy technology for lung cancer, colorectal cancer and breast cancer, interworking with domestic and overseas university hospitals and has decided to commercialize it as the recent clinical experiments have excellent achievements.

In these regards, EDGC has presented 'NGS Analysis Methods and Examples for Liquid Biopsy' at the International Symposium of Korean Society of Integrative Oncology which was held in South Korea on October 14th. The symposium covered the topic of anti-cancer immunotherapy; the Nobel Prize-winning field. In the symposium, greatest scholars such as Dr. Gary Deng of the Memorial Sloan Kettering Cancer Center in the United States and Prof. Ping-Ping Li of Peking University Cancer Hospital in China participated and discussed integrated cancer treatments. Therefore, it became a valuable opportunity for EDGC to show its liquid biopsy technology.